Ignite Creation Date:
2024-05-05 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 9:49 AM
Study NCT ID:
NCT00670774
Status:
COMPLETED
Last Update Posted:
2018-06-26
First Post:
2008-04-28
Brief Title:
Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant
Sponsor:
Mark Stegall
Organization:
Mayo Clinic
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-03
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-08
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-28
First Submit QC Date:
April 30 2008
Study First Post Date:
2008-05-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2018-06-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-23
Last Update Post Date:
2018-06-26
Last Update Post Date Type:
ACTUAL